{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:30:32Z","timestamp":1789122632051,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejim.2025.02.004","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T22:33:08Z","timestamp":1739313188000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Characterization of ischemic etiology in heart failure with reduced ejection fraction randomized clinical trials: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9063-5576","authenticated-orcid":false,"given":"Marco","family":"Canepa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0762-5551","authenticated-orcid":false,"given":"Gianluca","family":"Anastasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7167-7287","authenticated-orcid":false,"given":"Pietro","family":"Ameri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Vergallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2700-8478","authenticated-orcid":false,"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9854-5046","authenticated-orcid":false,"given":"Italo","family":"Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2025.02.004_bib0001","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ejim.2025.02.004_bib0002","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1161\/CIRCRESAHA.121.318172","article-title":"Epidemiology of heart failure: a contemporary perspective","volume":"128","author":"Roger","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.ejim.2025.02.004_bib0003","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ejhf.2115","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2025.02.004_bib0004","first-page":"ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2025.02.004_bib0005","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jacc.2021.12.011","article-title":"2022 AHA\/ACC\/HFSA Guideline for the management of Heart Failure: executive Summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2025.02.004_bib0006","doi-asserted-by":"crossref","DOI":"10.1161\/HCQ.0000000000000102","article-title":"2021 ACC\/AHA key data elements and definitions for Heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure)","volume":"14","author":"Bozkurt","year":"2021","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ejim.2025.02.004_bib0007","doi-asserted-by":"crossref","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2025.02.004_bib0008","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jchf.2014.10.007","volume":"3","author":"Desta","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ejim.2025.02.004_bib0009","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11897-022-00553-2","article-title":"The role of cardiac computed tomography in heart failure","volume":"19","author":"Kitchin","year":"2022","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.ejim.2025.02.004_bib0010","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.jacc.2021.03.310","article-title":"Impact of percutaneous coronary intervention on outcomes in patients with heart failure: JACC State-of-the-art review","volume":"77","author":"Parikh","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2025.02.004_bib0011","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1001\/jama.2013.1954","article-title":"Effect of Aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial","volume":"309","author":"Gheorghiade","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2025.02.004_bib0012","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ejim.2025.02.004_bib0013","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized Trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2025.02.004_bib0014","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa0912613","article-title":"Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure","volume":"363","author":"Massie","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.02.004_bib0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchf.2012.12.004","article-title":"Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ejim.2025.02.004_bib0016","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCHEARTFAILURE.107.740704","article-title":"Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure","volume":"1","author":"McMurray","year":"2008","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ejim.2025.02.004_bib0017","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jama.2009.2","article-title":"BNP-guided vs symptom-guided heart failure therapy: the trial of intensified vs standard medical therapy in elderly patients with congestive Heart failure (TIME-CHF) randomized trial","volume":"301","author":"Pfisterer","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2025.02.004_bib0018","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.02.004_bib0019","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jchf.2019.02.015","article-title":"Outcomes and effect of treatment according to etiology in HFrEF: an analysis of PARADIGM-HF","volume":"7","author":"Balmforth","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.ejim.2025.02.004_bib0020","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ejhf.2124","article-title":"Efficacy and safety of dapagliflozin according to aetiology in heart failure with reduced ejection fraction: insights from the DAPA-HF trial","volume":"23","author":"Butt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2025.02.004_bib0021","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027652","article-title":"Impact of Empagliflozin in heart failure with reduced ejection fraction in patients with ischemic versus nonischemic cause","volume":"12","author":"Khan","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2025.02.004_bib0022","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/CIRCHEARTFAILURE.114.001626","article-title":"Left ventricular reverse remodeling with biventricular versus right ventricular pacing in patients with atrioventricular block and heart failure in the BLOCK HF trial","volume":"8","author":"St John Sutton","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ejim.2025.02.004_bib0023","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ejim.2025.02.004_bib0024","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ejim.2025.02.004_bib0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0735-1097(01)01738-7","article-title":"A standardized definition of ischemic cardiomyopathy for use in clinical research","volume":"39","author":"Felker","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2025.02.004_bib0026","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.02.004_bib0027","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","article-title":"Rivaroxaban in patients with heart failure, Sinus rhythm, and coronary disease","volume":"379","author":"Zannad","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.02.004_bib0028","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.02.004_bib0029","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJMoa2206606","article-title":"Percutaneous revascularization for ischemic left ventricular dysfunction","volume":"387","author":"Perera","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.02.004_bib0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.hfc.2013.10.002","article-title":"The role of coronary artery disease in heart failure","volume":"10","author":"Lala","year":"2014","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.ejim.2025.02.004_bib0031","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ejhf.2468","article-title":"Vericiguat in patients with coronary artery disease and heart failure with reduced ejection fraction","volume":"24","author":"Saldarriaga","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2025.02.004_bib0032","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1002\/ejhf.2538","article-title":"Risk factors for the development of heart failure in patients with or without prior myocardial infarction","volume":"24","author":"van Essen","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2025.02.004_bib0033","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/aje\/kwg078","article-title":"Incidence of heart failure after myocardial infarction: is it changing over time?","volume":"157","author":"Hellermann","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejim.2025.02.004_bib0034","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026943","article-title":"Myocardial revascularization in patients with ischemic cardiomyopathy: for whom and how","volume":"12","author":"Liga","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2025.02.004_bib0035","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2025.02.004_bib0036","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0735-1097(03)00297-3","article-title":"Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia\u2013AMIOVIRT","volume":"41","author":"Strickberger","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2025.02.004_bib0037","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/CIRCULATIONAHA.106.623199","article-title":"Navigating the crossroads of coronary artery disease and heart failure","volume":"114","author":"Gheorghiade","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2025.02.004_bib0038","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jacc.2021.11.061","article-title":"Variability in coronary artery disease testing for patients with new-onset heart failure","volume":"79","author":"Zheng","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2025.02.004_bib0039","article-title":"Testing for coronary artery disease in older patients with new-onset heart failure","volume":"13","author":"O'Connor","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.ejim.2025.02.004_bib0040","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.amjcard.2016.03.002","article-title":"Geographic differences in patients in a global acute heart failure clinical trial (from the ASCEND-HF Trial)","volume":"117","author":"Metra","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2025.02.004_bib0041","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/ejhf.1130","article-title":"Globalization of heart failure clinical trials: a systematic review of 305 trials conducted over 16years","volume":"20","author":"Vaduganathan","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2025.02.004_bib0042","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/eurheartj\/ehw226","article-title":"Geographic variations in the PARADIGM-HF heart failure trial","volume":"37","author":"Kristensen","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2025.02.004_bib0043","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an Aldosterone antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2025.02.004_bib0044","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Gissi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2025.02.004_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100385","article-title":"Impact of statin therapy in heart failure patients","volume":"2","author":"Anderson","year":"2023","journal-title":"JACC Adv"},{"key":"10.1016\/j.ejim.2025.02.004_bib0046","first-page":"1564","article-title":"Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis","volume":"12","author":"Theuns","year":"2010","journal-title":"Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol"},{"key":"10.1016\/j.ejim.2025.02.004_bib0047","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021660","article-title":"Coronary artery disease and heart failure with preserved ejection fraction: the ARIC study","volume":"11","author":"John","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejim.2025.02.004_bib0048","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41569-021-00605-5","article-title":"Heart failure with mid-range or mildly reduced ejection fraction","volume":"19","author":"Savarese","year":"2022","journal-title":"Nat Rev Cardiol"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525000421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620525000421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T11:33:04Z","timestamp":1749123184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620525000421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":48,"alternative-id":["S0953620525000421"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2025.02.004","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of ischemic etiology in heart failure with reduced ejection fraction randomized clinical trials: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2025.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}